Neointimal patterns obtained by optical coherence tomography correlate with specific histological components and neointimal proliferation in a swine model of restenosis

European Heart Journal Cardiovascular Imaging

Volumn 15, Issue 3, 2014, Pages 292-298

  Kim, Jung Sun ^a,b   Afari, Maxwell E ^a   Ha, Jinyong ^b   Tellez, Armando ^a   Milewski, Krzysztof ^a   Conditt, Gerard ^a   Cheng, Yanping ^a   Hua Yi, Geng ^a   Kaluza, Greg L ^a   Granada, Juan F ^a  

^a CARDIOVASCULAR RESEARCH FOUNDATION   (United States)

^b Yonsei University College of Medicine   (South Korea)

Author keywords

Histology; Neointima; Optical coherence tomography; Optical intensity; Stent

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BARE METAL STENT; CELL INFILTRATION; CONNECTIVE TISSUE; CONTROLLED STUDY; CORONARY ARTERY; CROSS-SECTIONAL STUDY; DRUG ELUTING STENT; FIBRIN DEPOSITION; HISTOLOGY; IN-STENT RESTENOSIS; INFLAMMATION; INFLAMMATORY CELL; MORPHOLOGICAL TRAIT; NEOINTIMA; NONHUMAN; OPTICAL COHERENCE TOMOGRAPHY; OPTICAL COHERENCE TOMOGRAPHY DEVICE; OPTICS; PORCINE MODEL; PRIORITY JOURNAL; THICKNESS;

HISTOLOGY; NEOINTIMA; OPTICAL COHERENCE TOMOGRAPHY; OPTICAL INTENSITY; STENT;

ANGIOPLASTY, BALLOON, CORONARY; ANIMALS; BIOPSY, NEEDLE; CELL PROLIFERATION; CORONARY ANGIOGRAPHY; CORONARY RESTENOSIS; CORONARY STENOSIS; DISEASE MODELS, ANIMAL; DRUG-ELUTING STENTS; FEMALE; IMMUNOHISTOCHEMISTRY; MALE; METALS; NEOINTIMA; RANDOM ALLOCATION; STENTS; SWINE; TOMOGRAPHY, OPTICAL COHERENCE; TREATMENT OUTCOME;

EID: 84896723140     PISSN: 20472404     EISSN: None     Source Type: Journal    
DOI: 10.1093/ehjci/jet162     Document Type: Article

References (26)

1. Stone GW, Ellis SG, Cox DA, Hermiller J, OShaughnessy C, Mann JT et al. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med 2004;350:221-31.
2. Moses JW, Leon MB, Popma JJ, Fitzgerald PJ, Holmes DR, OShaughnessy C et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 2003;349:1315-23.
3. Joner M, Finn AV, Farb A, Mont EK, Kolodgie FD, Ladich E et al. Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk. J Am Coll Cardiol 2006;48:193-202.
4. Nakazawa G, Finn AV, Vorpahl M, Ladich ER, Kolodgie FD, Virmani R. Coronary responses and differential mechanisms of late stent thrombosis attributed to firstgeneration sirolimus- and paclitaxel-eluting stents. J Am Coll Cardiol 2011;57:390-8.
5. Finn AV, Joner M, NakazawaG, Kolodgie F, Newell J, JohnMCet al. Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization. Circulation 2007;115:2435-41.
6. Murata A,Wallace-Bradley D, Tellez A, Alviar C, Aboodi M, SheehyAet al. Accuracy of optical coherence tomography in the evaluation of neointimal coverage after stent implantation. J Am Coll Cardiol Imaging 2010;3:76-84.
7. Prati F, Regar E, Mintz GS, Arbustini E, Di Mario C, Jang IK et al. Expert review document on methodology, terminology, and clinical applications of optical coherence tomography: physical principles, methodology of image acquisition, and clinical application for assessment of coronary arteries and atherosclerosis. Eur Heart J 2009;31:401-15.
8. Templin C, Meyer M, Muller MF, Djonov V, Hlushchuk R, Dimova I et al. Coronary optical frequency domain imaging(OFDI) for in vivo evaluation of stent healing: comparison with light and electron microscopy. Eur Heart J 2010;31:1792-801.
9. Suzuki Y, Yeung AC, Ikeno F. The pre-clinical animal model in the translational research of interventional cardiology. J AmColl Cardiol Cardiovasc Interv 2009;2:373-83.
10. Kim JS, Jang IK, Kim TH, Takano M, Kume T, HurNWet al. Optical coherence tomography evaluation of zotarolimus-eluting stents at 9-month follow-up: comparison with sirolimus-eluting stents. Heart 2009;95:1907-12.
11. Kim JS, Jang IK, Fan C, Kim TH, Park SM, Choi EY et al. Evaluation in 3 months duration of neointimal coverage after zotarolimus-eluting stent implantation by optical coherence tomography: theENDEAVOROCTtrial. J AmColl Cardiol Cardiovasc Interv 2009; 2:1240-7.
12. Takano M, Yamamoto M, Seino Y, Mizuno K. Neovascular microchannels in sirolimus-eluting stent occlusion at late phase. J Am Coll Cardiol Cardiovasc Interv 2010;3:1202-3.
13. Gonzalo N, Serruys PW, Okamura T, Van Beusekom HM, Garcia-Garcia HM, Van Soest G et al. Optical coherence tomography patterns of stent restenosis. Am Heart J 2009;158:284-93.
14. Nakazawa G, Otsuka F, Nakano M, Vorpahl M, Yazdani SK, Ladich E et al. The pathology of neoatherosclerosis in human coronary implants bare-metal and drug-eluting stents. J Am Coll Cardiol 2011;57:1314-22.
15. Taylor AJ,Gorman PD, Farb A, Hoopes TG, Virmani R. Long-term coronary vascular response to (32)P beta-particle-emitting stents in a canine model. Circulation 1999; 100:2366-72.
16. Moreno PR, Fallon JT, Murcia AM, Leon MN, Simosa H, Fuster V et al. Tissue characteristics of restenosis after percutaneous transluminal coronary angioplasty in diabetic patients. J Am Coll Cardiol 1999;34:1045-9.
17. Coletta J, Suzuki N, Nascimento BR, Bezerra HG, Rosenthal N, Guagliumi G et al. Use of optical coherence tomography for accurate characterization of atherosclerosis. Arq Bras Cardiol 2010;94:250-4, 268-72, 254-9.
18. Jang IK, Bouma BE, Kang DH, Park SJ, Park SW, Seung KB et al. Visualization of coronary atherosclerotic plaques in patients using optical coherence tomography: comparison with intravascular ultrasound. J Am Coll Cardiol 2002;39:604-9.
19. Fujimoto JG, Boppart SA, Tearney GJ, Bouma BE, Pitris C, Brezinski ME. High resolution in vivo intra-Arterial imaging with optical coherence tomography. Heart 1999; 82:128-33.
20. Yabushita H, Bouma BE, Houser SL, Aretz HT, Jang IK, Schlendorf KH et al. Characterization of human atherosclerosis by optical coherence tomography. Circulation 2002;106:1640-5.
21. Takano M, Yamamoto M, Inami S, Murakami D, Ohba T, Seino Y et al. Appearance of lipid-laden intima and neovascularization after implantation of bare-metal stents extended late-phase observation by intracoronary optical coherence tomography. J Am Coll Cardiol J 2009;55:26-32.
22. Nagai H, Ishibashi-Ueda H, Fujii K. Histology of highly echolucent regions in optical coherence tomography images from two patients with sirolimus-eluting stent restenosis. Catheter Cardiovasc Interv 2010;75:961-3.
23. FinnAV, Kolodgie FD, Harnek J, Guerrero LJ, Acampado E, TeferaK et al. Differential response of delayed healing and persistent inflammation at sites of overlapping sirolimus- or paclitaxel-eluting stents. Circulation 2005;112:270-8.
24. Schwartz RS, Huber KC, Murphy JG, Edwards WD, Camrud AR, Vlietstra RE et al. Restenosis and the proportional neointimal response to coronary artery injury: results in a porcine model. J Am Coll Cardiol 1992;19:267-74.
25. Farb A, Burke AP, Kolodgie FD, Virmani R. Pathological mechanisms of fatal late coronary stent thrombosis in humans. Circulation 2003;108:1701-6.
26. Finn AV, Nakazawa G, Joner M, Kolodgie FD, Mont EK, Gold HK et al. Vascular responses to drug eluting stents: importance of delayed healing. Arterioscler Thromb Vasc Biol 2007;27:1500-10.